Ritonavir

• Target :

  SARS-CoV|||HIV Protease|||Apoptosis

• Related Pathways :

  Microbiology/Virology|||Proteases/Proteasome|||Apoptosis

• Purity :

  >99.99%

• Bioactivity :

  Ritonavir (ABT 538) is a peptidomimetic agent that inhibits both HIV-1 and HIV-2 proteases. Ritonavir is highly inhibited by serum proteins but boosts the effect of other HIV proteases by blocking their degradation by cytochrome P450.

• Smiles :

  CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1

• Molecular Formula :

  C37H48N6O5S2

• Molecular Weight :

  720.94

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  155213-67-5